
Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BNGO · as of Jun 8, 2026
Key Statistics
Explore Bionano Genomics, Inc. Data
bngo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
The BNGO analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $46.50, representing +3874.36% upside from the current price of $1.17.
Competitors & Peers
bngo competitorsStock Performance
Full HistoryAbout Bionano Genomics, Inc.
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and un…
what is bionano genomics, inc. · bngo stock overview · bionano genomics, inc. company profile · who is bionano genomics, inc. ceo · bngo NASDAQ · bionano genomics, inc. headquarters · bionano genomics, inc. business segments
About Stock Overview & Key Data
Bionano Genomics, Inc. (BNGO) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Aug 21, 2018. As of the latest trading session, BNGO stock price is $1.17, with a market capitalization of $3.8M. The stock has returned -68.12% over the past 12 months and -23.53% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Bionano Genomics, Inc. stock is Buy, with an average 12-month price target of $46.50. In fiscal year 2025, Bionano Genomics, Inc. reported revenue of $28.5M and net income of -$26.4M. For detailed data — including Bionano Genomics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bionano Genomics, Inc. (BNGO) stock price is $1.17. The stock is traded on NASDAQ under the ticker symbol BNGO. The 52-week range is $1.06 – $5.50.